James Fox, Director at GenMark Diagnostics, Inc. (GNMK), bought 9,000 shares at $5.50 ($50K) on 2020-03-06, disclosed to the SEC on 2020-03-10.
Open-market purchase of $50k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BOTA | BUY | 2015-06-11 | $139K | — | Filing → |
| GNMK | BUY | 2012-06-28 | $100K | — | Filing → |